“Scientists are poised to launch a phase 3 paediatric clinical trial of Chinese manufacturer Sinovac Biotech’s coronavirus vaccine in SA, as part of an international study that aims to evaluate the efficacy of

two doses of the Coronavac shot.” – Business Day (10 September 2021).

“The SA Health Products Regulatory Authority (SAHPRA) has so far only granted Coronavac emergency-use authorisation for adults aged between 18 and 59 years.

“The trial’s principal co-ordinator for SA, Sanet Aspinall, chief virologist at Sinovac’s local representative, Numolox, said China has, to date, administered about 60-m doses to 40-m children, and has found it to be very safe.

Other news